Search research articles
Contact Us
Filters
Showing results (211-220 of 230) with videos related to
Page
of 23
Sort By:
Leukemia
|
April 16, 2004
Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features
M Stevens-Kroef, B Poppe, S van Zelderen-Bhola, et al.
British Journal of Haematology
|
May 1, 1997
Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases
A Criel, G Verhoef, R Vlietinck, et al.
Leukemia
|
September 26, 1997
Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients. French Group for Treatment of Adult Acute Lymphoblastic Leukemia
A Delannoy, C Sebban, P Cony-Makhoul, et al.
British Journal of Haematology
|
April 1, 1996
Trisomy 3 in marginal zone B-cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization
J Dierlamm, L Michaux, I Wlodarska, et al.
Surgery
|
April 1, 1996
Laparoscopic splenectomy in adults and children: experience with 31 patients
J F Gigot, J de Ville de Goyet, B E Van Beers, et al.
Genes, Chromosomes & Cancer
|
October 23, 1997
FISH identifies different types of duplications with 12q13-15 as the commonly involved segment in B-cell lymphoproliferative malignancies characterized by partial trisomy 12
J Dierlamm, I Wlodarska, L Michaux, et al.
Leukemia
|
February 20, 2004
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias
P Vandenberghe, I Wlodarska, L Michaux, et al.
Blood
|
October 1, 1996
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group
E Wattel, A Guerci, B Hecquet, et al.
Leukemia
|
December 3, 2016
RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response
I J F Hofman, M van Duin, E De Bruyne, et al.
British Journal of Haematology
|
November 25, 1998
VAD or VMBCP in multiple myeloma refractory to or relapsing after cyclophosphamide-prednisone therapy (protocol MY 85)
P Mineur, J F Ménard, X Le Loët, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 230) with videos related to
Sort By:
Page
of 23
Leukemia
|
April 16, 2004
Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features
M Stevens-Kroef, B Poppe, S van Zelderen-Bhola, et al.
British Journal of Haematology
|
May 1, 1997
Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases
A Criel, G Verhoef, R Vlietinck, et al.
Leukemia
|
September 26, 1997
Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients. French Group for Treatment of Adult Acute Lymphoblastic Leukemia
A Delannoy, C Sebban, P Cony-Makhoul, et al.
British Journal of Haematology
|
April 1, 1996
Trisomy 3 in marginal zone B-cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization
J Dierlamm, L Michaux, I Wlodarska, et al.
Surgery
|
April 1, 1996
Laparoscopic splenectomy in adults and children: experience with 31 patients
J F Gigot, J de Ville de Goyet, B E Van Beers, et al.
Genes, Chromosomes & Cancer
|
October 23, 1997
FISH identifies different types of duplications with 12q13-15 as the commonly involved segment in B-cell lymphoproliferative malignancies characterized by partial trisomy 12
J Dierlamm, I Wlodarska, L Michaux, et al.
Leukemia
|
February 20, 2004
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias
P Vandenberghe, I Wlodarska, L Michaux, et al.
Blood
|
October 1, 1996
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group
E Wattel, A Guerci, B Hecquet, et al.
Leukemia
|
December 3, 2016
RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response
I J F Hofman, M van Duin, E De Bruyne, et al.
British Journal of Haematology
|
November 25, 1998
VAD or VMBCP in multiple myeloma refractory to or relapsing after cyclophosphamide-prednisone therapy (protocol MY 85)
P Mineur, J F Ménard, X Le Loët, et al.
Page
of 23